- Previous Close
29.48 - Open
26.20 - Bid --
- Ask --
- Day's Range
24.17 - 26.21 - 52 Week Range
16.90 - 30.22 - Volume
4,277,099 - Avg. Volume
1,636,527 - Market Cap (intraday)
22.747B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
-- - EPS (TTM)
-0.59 - Earnings Date Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 12, 2022
- 1y Target Est
26.60
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
www.philips.comRecent News: PHIA.AS
View More
Related Videos: PHIA.AS
Performance Overview: PHIA.AS
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHIA.AS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHIA.AS
View MoreValuation Measures
Market Cap
27.47B
Enterprise Value
33.92B
Trailing P/E
--
Forward P/E
15.77
PEG Ratio (5yr expected)
0.39
Price/Sales (ttm)
1.60
Price/Book (mrq)
2.31
Enterprise Value/Revenue
1.87
Enterprise Value/EBITDA
24.37
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.32%
Return on Assets (ttm)
1.36%
Return on Equity (ttm)
-4.59%
Revenue (ttm)
18.13B
Net Income Avi to Common (ttm)
-555M
Diluted EPS (ttm)
-0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81B
Total Debt/Equity (mrq)
69.35%
Levered Free Cash Flow (ttm)
1.85B
Research Analysis: PHIA.AS
View MoreCompany Insights: PHIA.AS
PHIA.AS does not have Company Insights